Gemcitabine and split-dose paclitaxel or docetaxel in metastatic breast cancer: A randomised phase II study

Gemcitabine and split-dose paclitaxel or docetaxel in metastatic breast cancer: A randomised phase II study

Purpose: The purpose was to evaluate the activity and toxicity of split-dose paclitaxel or docetaxel in combination with gemcitabine in patients with metastatic breast cancer (MBC) who had previously received anthracyclines. Patients and methods: A total of 210 patients were randomly assigned to one...

Full description

Saved in:
Bibliographic Details
Main Authors: Kei Siong Khoo, Syed Hasan Manzoor Zaidi, Vichien Srimuninnimit, Santai Song, Reena Nair, Corazon A. Ngelangel, Anita Bustam, William H.H. Reece, Manfred Lehnert
Other Authors: National Cancer Centre, Singapore
Format: Article
Published: 2018
Subjects:
Biochemistry, Genetics and Molecular Biology
Medicine
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/23004
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University

Internet

https://repository.li.mahidol.ac.th/handle/123456789/23004

Similar Items